Gabriella Fabbrocini

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 713 publications

GRINCH Index: Measuring Patient Satisfaction During Christmas Holiday Gift Programs.

GRINCH Index: Measuring Patient Satisfaction During Christmas Holiday Gift Programs.

Journal: Dermatology practical & conceptual

Published: June 11, 2025

Defining Predictive Factors for Permanent Chemotherapy-Induced Alopecia: Trichoscopy, Reflectance Confocal Microscopy and Histopathology Study on 77 Patients.

Defining Predictive Factors for Permanent Chemotherapy-Induced Alopecia: Trichoscopy, Reflectance Confocal Microscopy and Histopathology Study on 77 Patients.

Journal: Dermatology and therapy

Published: January 17, 2025

Phenotype-endotype relationship in elderly atopic dermatitis and effects of dupilumab therapy: prospective study.

Phenotype-endotype relationship in elderly atopic dermatitis and effects of dupilumab therapy: prospective study.

Journal: Archives of dermatological research

Published: January 06, 2025

Management and treatment of non-classic human scabies.

Management and treatment of non-classic human scabies.

Journal: Italian journal of dermatology and venereology

Published: February 02, 2024

Severe symptomatic late onset dermographism after mRNA COVID-19 vaccine.

Severe symptomatic late onset dermographism after mRNA COVID-19 vaccine.

Journal: Italian journal of dermatology and venereology

Published: January 23, 2024

Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study.

Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: December 01, 2023

Fixed-dose combination of calcipotriene/betamethasone dipropionate foam for the management of mild-to-moderate psoriasis in daily clinical practice: a collection of clinical experiences.

Fixed-dose combination of calcipotriene/betamethasone dipropionate foam for the management of mild-to-moderate psoriasis in daily clinical practice: a collection of clinical experiences.

Journal: Drugs in context

Published: November 28, 2023

Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe Psoriasis.

Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe Psoriasis.

Journal: Journal of clinical medicine

Published: November 24, 2023

Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History.

Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History.

Journal: American journal of clinical dermatology

Published: November 07, 2023

Efficacy, tolerability and patient's satisfaction for the treatment of moderate to severe plaque psoriasis with apremilast in the real-life setting of Campania region, Italy.

Efficacy, tolerability and patient's satisfaction for the treatment of moderate to severe plaque psoriasis with apremilast in the real-life setting of Campania region, Italy.

Journal: Italian journal of dermatology and venereology

Published: September 18, 2023

AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History.

AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History.

Journal: American journal of clinical dermatology

Published: August 28, 2023

A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years.

A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years.

Journal: The Journal of dermatological treatment

Published: August 15, 2023

Showing 1-12 of 713

Last Updated: 09/26/2026